TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Purpose
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Condition
- Cancer
Eligibility
- Eligible Ages
- Between 18 Years and 99 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- ≥18 years of age 2. Willing to participate in the research 3. Able to provide informed consent 4. Must be diagnosed with cancer
Exclusion Criteria
- Not willing or able to have additional blood samples collected
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Cohort 001: KRAS mutated CRC | No intervention. | |
Cohort 002: KRAS mutated PDAC | No intervention. | |
Cohort 003: KRAS mutated NSCLC | No intervention. | |
Cohort 004: Gastric 1L Plus | No intervention. | |
Cohort 005: mCRPC 1L Plus | No intervention. | |
Cohort 006: Pan Tumor ADCs | No intervention. |
Recruiting Locations
Whittier, California 90605
Norwich, Connecticut 06360
Jacksonville, Florida 32256
Carterville, Illinois 62918
Hinsdale, Illinois 60521
O'Fallon, Illinois 62269
Peoria, Illinois 61615
Rolling Meadows, Illinois 60008
Goshen, Indiana 46526
Morehead, Kentucky 40351
Frederick, Maryland 21702
Fairhaven, Massachusetts 02719
Hannibal, Missouri 63401
Springfield, Missouri 65807
Las Vegas, Nevada 89103
Reno, Nevada 89511
Belleville, New Jersey 07109
Belleville, New Jersey 07109
East Syracuse, New York 13057
Ithaca, New York 14850
Fargo, North Dakota 58102
Maumee, Ohio 43537
York, Pennsylvania 17403
Rio Piedras, Puerto Rico 00935
More Details
- NCT ID
- NCT06207032
- Status
- Recruiting
- Sponsor
- Tempus AI